CHEMonitor – New Study Results Published 

The CHEMonitor study highlights the crucial importance of innovation for Europe’s future as a hub for the chemical and pharmaceutical industries. Industry managers identify key prerequisites:

• 52% see Europe losing ground as an innovation location, while 84% agree that targeted investments in infrastructure, digitalization, and AI could make Europe a global innovation leader.
• Top demands: more innovation-friendly regulations and faster approval procedures (77%), as well as competitive energy prices through the creation of a European energy market (67%).
• Within companies: an innovation-friendly culture (82%), investments in digital tools (80%), the promotion of interdisciplinary and cross-functional teams (78%), and agile or iterative innovation processes (65%).
• Major drivers: development partnerships between customers and suppliers (90%) and stronger links between science and industry (84%).
• High potential for global innovation and market leadership in Europe is seen particularly in biotechnology, technologies and processes enabling the circular economy, and safe and sustainable chemicals (green chemistry).

The accompanying time series on location conditions and forecasts continues to paint a critical picture. A worrying finding: 56% of respondents report planned job cuts – a figure more than twice as high as during 2020/2021.

Full study results are available at https://chemanager-online.com/de/themen/chemonitor-2-2025-europa-innovationsstandort-mit-zukunft.

CHEMonitor is the leading trend barometer of Germany’s chemical and pharmaceutical industries, conducted by CHEManager and Santiago Advisors. More information: www.chemonitor.com